AU Patent

AU723901B2 — Immunogenic peptides of foot-and-mouth disease viruses

Assigned to Bayer AG · Expires 2000-09-07 · 26y expired

What this patent protects

Patent listed against Auryxia.

Drugs covered by this patent

Auryxia (FERRIC CITRATE) · Keryx Biopharms

Patent Metadata

Patent number: AU723901B2
Jurisdiction: AU
Classification: —
Expires: 2000-09-07
Drug substance claim: No
Drug product claim: No
Assignee: Bayer AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.